Loss of heterozygosity of p53 in congenital sacrococcygeal teratomas (CROSBI ID 117021)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Podaci o odgovornosti
Krušlin, Božo ; Gall-Trošelj, Koraljka ; Čizmić, Ante ; Čupić, Hrvoje ; Turčić, Marijana ; Belicza, Malden
engleski
Loss of heterozygosity of p53 in congenital sacrococcygeal teratomas
Congenital sacrococcygeal teratoma (CSCT) is the most common germ cell tumor of infancy and childhood. The tumor is benign, consists of fully differentiated mature tissues but may also contain immature tissues derived from all three germinal layers. It is usually diagnosed at birth. Mutations of p53 gene have been found in more than 50% of human cancers, however, there are few data regarding the expression of p53 in CSCT. In this study we analyzed loss of heterozygosity (LOH) of p53 in nine CSCT by polymerase chain reaction/ restriction fragment length polymorphism (PCR/RFLP) based on two polymorphous sites (Bst U1 and Msp 1). CSCTs were diagnosed in 8 female and 1 male children aging from 3-30 days. The tumors measured from 5.5 to 17 cm in largest diameter. LOH was detected in one tumor sample. Six samples were non-informative (homozygous) for both analyzed markers, while two samples were informative for BstUI, but without LOH in tumor tissue. p53 positive immunostaining was found in 4 tumors. It seems that LOH of p53 is a rare genetic event in congenital CSCT. However, it is obvious that more studies on larger groups of patients are needed.
congenital sacrococcygeal teratoma; p53; LOH; Teratoma; protein p53; loss of heterizygosity
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano